CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Eurofins-Cerep SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Eurofins-Cerep SA
Le bois l'Eveque
Phone: +33 549893000p:+33 549893000 CELLE-LEVESCAULT, 86600  France Ticker: ALECRALECR
This company was Merged or Acquired on 2/12/2013.
This is a Subsidiary, click here for the Parent Company
Business Summary
Eurofins-Cerep SA, formerly Cerep SA is a France-based company that specializes in the pre-clinical research, discovery and development of new pharmaceutical drugs. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The Company then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. The Company’s maximum revenue is generated through Exports accounts.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations
2835 In vitro and in vivo diagnostic substances
7372 Prepackaged software
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board DamienSeroux 4/19/2018 10/13/2014
Chief Executive Officer, Director AntoineDuthilleul 4/19/2018 4/19/2018
Director ChristinaShasserre 6/10/2015 6/10/2015

Business Names
Business Name
ALECR
Cerep SA
ECRT

General Information
Number of Employees: 233 (As of 6/30/2023)
Outstanding Shares: 5,044 (As of 6/30/2023)
Shareholders: 97,855
Stock Exchange: EPA
Federal Tax Id: 911862341
Fax Number: +33 549432170


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024